A stunning 40 percent of what we eat is added sugars and refined carbs, says Christopher Gardner, professor of medicine at the Stanford University School of Medicine
These results project that retatrutide may have a greater efficacy than tirzepatide and semaglutide due to its triple action at GLP-1, GIP, and glucagon receptors
Injectable semaglutide is taken once weekly
Many patients lose 1020% of their body weight while also improving: Blood sugar regulation Appetite control Blood pressure Overall metabolic health At Be Well Medical Group, we prescribe FDA-approved GLP-1 medications when appropriate and tailor treatment based on your goals, response, and tolerance
Efficacy and tolerability outcomes in the type 2 diabetes Phase 2 trial were broadly consistent with these findings
Opdualags relatlimab component carries a composition-of-matter patent through approximately 2032